AAAAAA
Results: 1-25/31
Authors:
Gail, MH
Brown, LM
You, WC
Citation: Mh. Gail et al., Re: Chemoprevention of gastric dysplasia: Randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy, J NAT CANC, 93(7), 2001, pp. 559-559
Authors:
Gail, MH
Costantino, JP
Citation: Mh. Gail et Jp. Costantino, Validating and improving models for projecting the absolute risk of breastcancer, J NAT CANC, 93(5), 2001, pp. 334-335
Authors:
You, WC
Zhang, L
Pan, KF
Jiang, J
Chang, YS
Perez-Perez, GI
Liu, WD
Ma, JL
Gail, MH
Blaser, MJ
Fraumeni, JF
Xu, GW
Citation: Wc. You et al., Helicobacter pylori prevalence and CagA status among children in two counties of china with high and low risks of gastric cancer, ANN EPIDEMI, 11(8), 2001, pp. 543-546
Authors:
You, WC
Chang, YS
Heinrich, J
Ma, JL
Liu, WD
Zhang, L
Brown, LM
Yang, CS
Gail, MH
Fraumeni, JF
Xu, GW
Citation: Wc. You et al., An intervention trial to inhibit the progression of precancerous gastric lesions: compliance, serum micronutrients and S-allyl cysteine levels, and toxicity, EUR J CAN P, 10(3), 2001, pp. 257-263
Authors:
Moore, DF
Chatterjee, N
Pee, D
Gail, MH
Citation: Df. Moore et al., Pseudo-likelihood estimates of the cumulative risk of an autosomal dominant disease from a kin-cohort study, GENET EPID, 20(2), 2001, pp. 210-227
Authors:
De Gruttola, VG
Clax, P
DeMets, DL
Downing, GJ
Ellenberg, SS
Friedman, L
Gail, MH
Prentice, R
Wittes, J
Zeger, SL
Citation: Vg. De Gruttola et al., Considerations in the evaluation of surrogate endpoints in clinical trials: Summary of a National Institutes of Health Workshop, CONTR CL TR, 22(5), 2001, pp. 485-502
Authors:
Brown, LM
Thomas, TL
Ma, JL
Chang, YS
You, WC
Liu, WD
Zhang, L
Gail, MH
Citation: Lm. Brown et al., Helicobacter pylori infection in rural China: Exposure to domestic animalsduring childhood and adulthood, SC J IN DIS, 33(9), 2001, pp. 686-691
Authors:
Pfeiffer, RM
Gail, MH
Pee, D
Citation: Rm. Pfeiffer et al., Inference for covariates that accounts for ascertainment and random genetic effects in family studies, BIOMETRIKA, 88(4), 2001, pp. 933-948
Authors:
Gail, MH
Costantino, JP
Bryant, J
Croyle, R
Freedman, L
Helzlsouer, K
Vogel, V
Citation: Mh. Gail et al., Re: Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer - Response, J NAT CANC, 92(9), 2000, pp. 758-758
Authors:
Gail, MH
Costantino, JP
Bryant, J
Croyle, R
Freedman, L
Helzlsouer, K
Vogel, V
Citation: Mh. Gail et al., Re: Risk/benefit assessment of tamoxifen to prevent breast cancer - Still a work in progress?, J NAT CANC, 92(7), 2000, pp. 574-574
Authors:
You, WC
Zhang, L
Gail, MH
Chang, YS
Liu, WD
Ma, JL
Li, JY
Jin, ML
Hu, YR
Yang, CS
Blaser, MJ
Correa, P
Blot, WJ
Fraumeni, JF
Xu, GW
Citation: Wc. You et al., Gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors, J NAT CANC, 92(19), 2000, pp. 1607-1612
Authors:
Fears, TR
Ziegler, RG
Donaldson, JL
Falk, RT
Hoover, RN
Stanczyk, FZ
Vaught, JB
Gail, MH
Citation: Tr. Fears et al., Reproducibility studies and interlaboratory concordance for androgen assays in female plasma, CANC EPID B, 9(4), 2000, pp. 403-412
Authors:
Carroll, RJ
Gail, MH
Benichou, J
Pee, D
Citation: Rj. Carroll et al., Score tests for familial correlation in genotyped-proband designs, GENET EPID, 18(4), 2000, pp. 293-306
Authors:
You, WC
Ma, JL
Liu, WD
Gail, MH
Chang, YS
Zhang, L
Hu, YR
Fraumeni, JF
Xu, GW
Citation: Wc. You et al., Blood type and family cancer history in relation to precancerous gastric lesions, INT J EPID, 29(3), 2000, pp. 405-407
Authors:
Schafer, H
Gail, MH
Royston, P
Citation: H. Schafer et al., Selected papers from the Oberwolfach Conference on Medical Statistics: Mathematical models for diagnosis and prognosis - Preface, STAT MED, 19(4), 2000, pp. 421-421
Authors:
Gail, MH
Greene, MH
Citation: Mh. Gail et Mh. Greene, Gail model and breast cancer, LANCET, 355(9208), 2000, pp. 1017-1017
Authors:
Fears, TR
Gail, MH
Citation: Tr. Fears et Mh. Gail, Analysis of a two-stage case-control study with cluster sampling of controls: Application to nonmelanoma skin cancer, BIOMETRICS, 56(1), 2000, pp. 190-198
Authors:
Gail, MH
Costantino, JP
Bryant, J
Croyle, R
Freedman, L
Helzlsouer, K
Vogel, V
Citation: Mh. Gail et al., Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer, J NAT CANC, 91(21), 1999, pp. 1829-1846
Authors:
Costantino, JP
Gail, MH
Pee, D
Anderson, S
Redmond, CK
Benichou, J
Wieand, HS
Citation: Jp. Costantino et al., Validation studies for models projecting the risk of invasive and total breast cancer incidence, J NAT CANC, 91(18), 1999, pp. 1541-1548
Authors:
Falk, RT
Gail, MH
Fears, TR
Rossi, SC
Stanczyk, F
Adlercreutz, H
Kiura, P
Wahala, K
Donaldson, JL
Vaught, JB
Fillmore, CM
Hoover, RN
Ziegler, RG
Citation: Rt. Falk et al., Reproducibility and validity of radioimmunoassays for urinary hormones andmetabolites in pre- and postmenopausal women, CANC EPID B, 8(6), 1999, pp. 567-577
Authors:
Potischman, N
Gail, MH
Troisi, R
Wacholder, S
Hoover, RN
Citation: N. Potischman et al., Measurement error does not explain the persistence of a body mass index association with endometrial cancer after adjustment for endogenous hormones, EPIDEMIOLOG, 10(1), 1999, pp. 76-79
Authors:
Gail, MH
Pee, D
Benichou, J
Carroll, R
Citation: Mh. Gail et al., Designing studies to estimate the penetrance of an identified autosomal dominant mutation: Cohort, case-control, and genotyped-proband designs, GENET EPID, 16(1), 1999, pp. 15-39
Authors:
Gail, MH
Rimer, BK
Citation: Mh. Gail et Bk. Rimer, Risk of risk-based mammography screening, ages 40 to 49 - In reply, J CL ONCOL, 17(2), 1999, pp. 737-738
Authors:
Gail, MH
Citation: Mh. Gail, Some of Nathan Mantel's contributions to epidemiology, STAT MED, 18(24), 1999, pp. 3389-3400
Authors:
Bilker, WB
Berlin, JA
Gail, MH
Strom, BL
Citation: Wb. Bilker et al., An efficient design for verifying disease outcome status in large cohorts with rare exposures and low disease rates, STAT MED, 18(22), 1999, pp. 3021-3036